Skip to main content

Table 1 Participant characteristics at baseline

From: A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease

Characteristics

Total (n = 194)

AD (n = 122)

DLB (n = 72)

p Value*

Age, yr (SD)

75.8 (7.6)

75.7 (7.8)

76.0 (7.3)

0.951

Women, n (%)

122 (62.9)

90 (73.6)

32 (44.4)

<0.001

Education, yr (SD)

9.6 (2.9)

9.6 (3.0)

9.6 (2.9)

0.851

MMSE, mean (SD)

23.5 (2.7)

23.6 (2.3)

23.3 (3.1)

0.693

CDR-Global, median (IQR)

1.0 (0.5)

1.0 (0.5)

1.0 (0.5)

0.071

NPI anxiety, mean (SD)

1.8 (3.0)

1.5 (2.7)

2.2 (3.6)

0.197

NPI depression, mean (SD)

2.0 (2.6)

1.9 (2.5)

2.4 (2.7)

0.147

NPI total, mean (SD)

18.5 (17.3)

15.6 (16.0)

23.7 (18.2)

0.001

MADRS anxiety, median (IQR)

0 (2)

0 (2)

1 (2)

0.109

Clinically significant anxiety, % (median/IQR)

19.9

18.6 (6/4)

22.1 (8/8)

0.237

Non–clinically significant anxiety, % (median/IQR)

80.1

81.4 (0/0)

77.9 (0/1)

0.204

  1. Abbreviations: AD Alzheimer’s disease, DLB Dementia with Lewy bodies, MMSE Mini Mental State Examination, CDR Clinical Dementia Rating, IQR interquartile range, NPI Neuropsychiatric Inventory, MADRS Montgomery–Åsberg Depression Rating Scale, SD standard deviation
  2. *Differences between the AD and DLB groups were analysed using the Mann-Whitney U test and Pearson’s χ 2 test